← Browse by Condition
Medical Condition
gestational diabetes
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3
Diabetes clinical trials span both type 1 (autoimmune beta-cell destruction) and type 2 (insulin resistance) disease, with growing focus on the overlapping spectrum including latent autoimmune diabetes in adults (LADA) and monogenic forms. Research priorities include beta-cell preservation in newly diagnosed type 1 patients, weight-loss-independent glucose control, and prevention of cardiovascular and renal complications.
Current trials evaluate GLP-1/GIP dual agonists (tirzepatide analogs), oral insulin formulations, closed-loop artificial pancreas systems, immunotherapy for type 1 delay, SGLT2 inhibitors in non-diabetic heart failure, and stem-cell-derived islet transplantation. Lifestyle intervention trials also remain an active category.
Many trials separate type 1 and type 2 cohorts; baseline HbA1c, duration of disease, and eGFR are common eligibility criteria.
Frequently Asked Questions — gestational diabetes Clinical Trials
How many clinical trials are currently recruiting for gestational diabetes?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for gestational diabetes, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gestational diabetes?
gestational diabetes research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gestational diabetes clinical trial?
Eligibility criteria for gestational diabetes trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07336914
Recruiting
Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes
Enrollment
60 pts
Location
Pakistan
Sponsor
Khyber Medical University Pesh...
NCT06571487
Recruiting
Growth Hormone Resistance of Beta-cells A
Enrollment
30 pts
Location
United States
Sponsor
University of Missouri-Columbi...
NCT06416995
Recruiting
Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes
Enrollment
88 pts
Location
Turkey (Türkiye)
Sponsor
Umraniye Education and Researc...
NCT05081037
Recruiting
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
Enrollment
300 pts
Location
Singapore
Sponsor
KK Women's and Children's Hosp...
NCT06445530
Recruiting
Nutrition Optimization and Community Upliftment for Postpartum Recovery
Enrollment
40 pts
Location
United States
Sponsor
Johns Hopkins University
NCT02947503 Phase 3
Recruiting
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Enrollment
500 pts
Location
Netherlands
Sponsor
Bethesda Diabetes Research Cen...
NCT03830879
Recruiting
Shenzhen Birth Cohort Study
Enrollment
10,000 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06457139
Recruiting
Preventing T2DM After GDM With Immediate Postpartum Screening
Enrollment
116 pts
Location
United States
Sponsor
University of Massachusetts, W...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology